Evidence map›Paper›PMID 38599768›Full record

ArticleHuman vaccines & immunotherapeutics2024

A real-world study on the changing characteristics of measles antibodies in premature infants in China.

Mingyan Li, Weiwei Zhang, Shuangshuang Zheng, Junxia Guo, Hanqing He, Yongjun Ma, Yan Huang, Yan Feng, Chai Ji

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Mingyan LiDepartment of Child Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Weiwei ZhangDepartment of Child Health Care, Maternal and Child Health Hospital of Changxing, Huzhou, China.
Shuangshuang ZhengDepartment of Child Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Junxia GuoDepartment of Child Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Hanqing HeDepartment of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Yongjun MaDepartment of Pediatrics, Maternal and Child Healthcare Hospital Department of Shangyu, Shaoxing, China.
Yan HuangDepartment of Immunization Program, Center for Disease Control and Prevention of Shangyu, Shaoxing, China.
Yan FengDepartment of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Chai JiDepartment of Child Health Care, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.ORCID 0000-0002-2062-0616
National Clinical Research · USZhejiang Center for Disease Control and Prevention · CNTaiwan Centers for Disease Control · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The waning of maternal antibodies may cause infants to lose protection against measles before receiving measles-containing vaccine (MCV). The aim of this study is to investigate the changing characteristics and influencing factors of measles antibodies in preterm infants (PT), and to provide scientific basis for optimizing MCV vaccination strategy of the target population. Blood samples were collected from PT and full-term infants (FT) at the chronological age (CA) of 3, 6, and 12 months. Measles antibodies were quantitatively detected by enzyme-linked immunosorbent assay. Demographic and vaccination information were both collected. Kruskal-Wallis rank sum test was used to compare the measles antibodies among different gestation age (GA) groups, and multiple linear regression was performed to identify the correlative factors for the antibodies. Measles antibodies of PT decreased significantly with age increasing before MCV vaccination. The positive rates of antibodies of PT were 10.80% and 3.30% at the age of 3 and 6 months, respectively (

Indexed as

Infant, PrematureMeaslesAntibodies, ViralChinaHumansInfantInfant, NewbornMeasles VaccineMeasles virusVaccinationAntibodies, ViralMeasles Vaccinecorrelative factorsMeaslesmeasles antibodymeasles-containing vaccinepreterm infants

Identifiers

PMID38599768
PMCPMC11008540
OpenAlexW4394762816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.